Complications of lymphangiomas in children

Hancock, B.J.; St-Vil, Dickens; Luks, François I.; Lorenzo, Maria Di; Blanchard, H

doi:10.1016/0022-3468(92)90316-y

Cited by 257 publications

(179 citation statements)

References 28 publications

Supporting

Mentioning

141

Contrasting

Unclassified

Order By: Relevance

“…This could explain blood effusion far from surgical site in the patient. In literature surgical complications, which occur in 19-33% of the cases, include formation of hematoma, lymphocele, scar, abscess, infection, wound dehiscence and nerve palsy have been noticed by several authors [14,[16][17][18].…”

Section: Discussionmentioning

confidence: 99%

Simultaneous hemopericardium, hemoperitoneum and hemothorax after complete surgical resection of mediastinal cystic lymphangioma: A case report

Kumba¹,

Banchini²,

Conti³

et al. 2017

IJCRI

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Simultaneous hemopericardium, hemoperitoneum and hemothorax after complete surgical resection of mediastinal cystic lymphangioma: A case report

Kumba¹,

Banchini²,

Conti³

et al. 2017

IJCRI

View full text Add to dashboard Cite

“…Other treatment methods are palliative surgical treatment or sclerosing agents. There are still high recurrence rates for the totally excised and incompletely resected mesenteric cystic lymphangiomas, and this indicates a continuing need to develop new and effective treatment options to supplement surgery (9).…”

Section: Discussionmentioning

confidence: 99%

Cystic Lymphangioma Involving the Mesentery and the Retroperitoneum: A Case Report

Kim

Byun

Jang

2005

J Korean Radiol Soc

View full text Add to dashboard Cite

Cystic lymphangiomas involving the mesentery and the retroperitoneum are rare tumors. Most of the cystic lymphangiomas occur in the neck, and they generally have a single cavity with only only a small proportion of these tumor being multilocular. The cystic spaces are lined with a single layer of endothelium and there are small lymphoid aggregates in the cyst's wall that help distinguish lymphangiomas from the simple cysts of the mesentery. We describe here an uncommon case of cystic lymphangioma presenting as a multilocular mass involving the mesentery and the retroperitoneum. CaseA 20-year-old male patient was referred to the department of general surgery for an operation on an intraabdominal mass that was incidentally detected. He had back pain after minor trauma 4 weeks earlier, and magnetic resonance imaging (MRI) demonstrated a huge cystic mass extending from the upper intraabdominal cavity to the pelvic cavity, and there was herniation of the nucleus pulposus at the L4 5 level (Fig. 1A). The patient's past medical history was unremarkable and he was asymptomatic. The physical examination revealed a blood pressure of 100/80 mm Hg, a pulse of 80 beats/min, respiration of 24 breaths/min, and a body temperature of 36.5 . There was no palpable mass in the abdomen and the bowel sounds were hypoactive. The laboratory data on admission, including the blood chemistry profile, coagulation studies and complete blood count revealed unremarkable findings. An admission abdominal X-ray showed diffuse increased opacity that suggested a soft tissue mass in the abdomen. The transabdominal ultrasonography (US) revealed a multiseptated cystic mass without any definite wall (Fig. 1B) Cystic lymphangioma is uncommon angiomatous tumor that mainly occurs in the neck. Less than 1% of these tumors affect the mesentery, retroperitoneum and greater omentum. In particular, the cystic lymphangioma involving the mesentery and the retroperitoneum is a rare lesion. We report here on an uncommon case of cystic lymphangioma that presented as a multilocular mass involving the mesentery and the retroperitoneum, and we also present a brief review of the relevant literature.

show abstract

“…Embora histologicamente benigno, devido ao seu cará-ter infiltrativo, o linfangioma pode expandir para dentro dos tecidos adjacentes e/ou estruturas vitais, causando complicações, algumas ameaçadoras à vida 1,2,4,5,8,9 . Há relatos de regressão espontânea, porém a sua ocorrência não é comum.…”

Section: Introductionunclassified

“…A região da cabeça e do pescoço permanece a mais freqüen-temente comprometida, seguida pela extremidade, tronco e abdômen 3,4,[7][8][9] . Normalmente esta lesão é assintomática, tornando-se evidente como uma massa cística, indolor, aderida aos planos profundos, recoberta por pele normal, com crescimento lento e tamanho flutuante.Embora histologicamente benigno, devido ao seu cará-ter infiltrativo, o linfangioma pode expandir para dentro dos tecidos adjacentes e/ou estruturas vitais, causando complicações, algumas ameaçadoras à vida 1,2,4,5,8,9 . Há relatos de regressão espontânea, porém a sua ocorrência não é comum.…”

unclassified

Treatment of lymphangioma with interferon-alpha-2a

Souza¹,

Tone²

2001

J Pediatr (Rio J)

View full text Add to dashboard Cite

ResumoObjetivo: descrever os resultados obtidos com o uso do alfa-2a-interferon no tratamento de pacientes pediátricos com linfangiomas irressecáveis ou refratários a outros tratamentos.Método: após revisão da literatura sobre a patogenia e os tratamentos disponíveis para os linfangiomas, utilizamos o alfa-2a-interferon na dosagem de 3 milhões de unidades/m 2 /dia, via subcutânea, para tratamento de pacientes que apresentavam lesões irressecáveis. Para avaliar o grau de resposta e os efeitos colaterais foram realizadas avaliações clínicas e laboratoriais periódicas.Resultados: observamos que os 6 pacientes com linfangiomas irressecáveis que utilizaram alfa-2a-interferon obtiveram uma resposta clínica satisfatória associada a efeitos colaterais mínimos. Cinco destes evoluíram com regressão parcial de suas lesões e 1 com estabilização da doença.Conclusão: concluímos que o alfa-2a-interferon constitui uma das armas disponíveis para o tratamento dos linfangiomas inoperá-veis na infância.J Pediatr (Rio J) 2001; 77 (2): 139-42: linfangioma, higroma cístico, interferon. AbstractObjective: to describe the results of the use of alpha-2a-interferon in the treatment of inoperable childhood lymphangiomas refractory to other therapeutic management.Method: we reviewed the literature about pathogenic events and the treatments available for lymphangiomas. Based on that, we used alpha-2a-interferon at a dose of 3 million units/m 2 /day administered subcutaneously to patients with inoperable disease and no response to other treatments. We conducted periodic clinical and laboratory control to evaluate the response and the adverse reactions to alpha2a-interferon administration.Results: we observed that the 6 patients with inoperable lymphangiomas who used alpha-2a-interferon had a satisfactory clinical response associated with minimum adverse reactions. Of these patients, 5 had partial regression of their lesions, and 1 remained stable.Conclusion: alpha-2a-interferon may be one more available treatment for inoperable childhood lymphangiomas.J Pediatr (Rio J) 2001; 77 (2): 139-42: lymphangioma, cystic hygroma, interferon. Tratamento clínico do linfangioma com alfa-2a-interferon Treatment of lymphangioma with alpha-2a-interferonReynaldo J.S.P. de Souza 1 , Luiz G. Tone 2 IntroduçãoA definição de linfangioma, primeiramente descrito em 1828 por Redenbacher (apud Martinot, 1997) 1 , permanece controversa. Alguns autores o consideram uma malformação congênita do sistema linfático 2-5 , enquanto outros um hamartoma congênito 3,6 ou um tumor vascular benigno decorrente da proliferação de vasos linfáticos 7 .A sua ocorrência é relativamente rara 1,6,8 , sendo observado principalmente nos dois primeiros anos de vida. A região da cabeça e do pescoço permanece a mais freqüen-temente comprometida, seguida pela extremidade, tronco e abdômen 3,4,[7][8][9] . Normalmente esta lesão é assintomática, tornando-se evidente como uma massa cística, indolor, aderida aos planos profundos, recoberta por pele normal, com crescimento lento e tamanho flutuante...

show abstract

Complications of lymphangiomas in children

Cited by 257 publications

References 28 publications

Simultaneous hemopericardium, hemoperitoneum and hemothorax after complete surgical resection of mediastinal cystic lymphangioma: A case report

Simultaneous hemopericardium, hemoperitoneum and hemothorax after complete surgical resection of mediastinal cystic lymphangioma: A case report

Cystic Lymphangioma Involving the Mesentery and the Retroperitoneum: A Case Report

Treatment of lymphangioma with interferon-alpha-2a

Contact Info

Product

Resources

About